Timing medical examinations via intensity functions

Biometrika

Volumn 84, Issue 4, 1997, Pages 803-816

  Parmigiani, Giovanni ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Chronic disease; Design; Medical decision making; Optimisation; Screening

Indexed keywords

EID: 0000742246     PISSN: 00063444     EISSN: None     Source Type: Journal    
DOI: 10.1093/biomet/84.4.803     Document Type: Article

References (32)

1. ALBERT, A., GERTMAN, M., Liu, S. I. Louis, T. A. (1978). Screening for the early detection of cancer, I: The temporal natural history of a progressive disease state. Math. Biosci. 40, 1-59.
2. ALBERT, A., GERTMAN, M. Louis, T. A. (1978). Screening for the early detection of cancer, II: The impact of screening on the natural history of disease. Math. Biosci. 40, 61-109.
3. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS (1995). ACOG committee opinion. Recommen-dations of frequency of Pap test screening. Int. J. Gynaecol. Obstet. 49, 210-1.
4. BARLOW, R. E., HUNTER, L. C. PROSCHAN, F. (1963). Optimum checking procedures. J. Soc. Indust. Appl. Math. 4, 1078-95.
5. CLYDE, M. A. CHALONER, K. (1996). The equivalence of constrained and weighted designs in multiple objective design problems. J. Am. Statist. Assoc. 91, 1236-44.
6. EDDY, D. M. (1983). A mathematical model for timing repeated medical tests. Med. Decis. Making 3, 34-62.
7. EDDY, D. M. SHWARTZ, M. (1982). Mathematical models in screening. In Cancer Epidemiology and Prevention, Ed. D. Schottenfeld and J. F. Fraumeni Jr, pp. 1075-90. Philadelphia: Saunders.
8. GUSTAFFSON, L. AoAMi, H. O. (1992). Optimization of cervical cancer screening. Cancer Causes Contr. 3, 125-36.
9. KELLER, J. B. (1974). Optimum checking schedules for systems subject to random failure. Manag. Sci. 21, 256-60.
10. KELLER, J. B. (1982). Optimum inspection policies. Manag. Sci. 28, 447-50.
11. KIRCH, R. L. A. KLEIN, M. (1974). Surveillance schedules for medical examinations. Manag. Sci. 20,1403-9.
12. LAGAKOS, S. W. Louis, T. A. (1988). Use of tumour lethality to interpret tumourigenicity experiments lacking cause-of-death data. Appl. Statist. 37, 169-79.
13. LINCOLN, T. L. WEISS, G. H. (1964). A statistical evaluation of recurrent medical evaluations. Oper. Res. 12, 187-205.
14. Louis, T. A., ALBERT, A. HEGHINIAN, S. (1978). Screening for the early detection of cancer, III: Estimation of disease natural history. Math. Biosci. 40, 111-44.
15. MANTON, K. G. STALLARD, E. (1988). Chronic Disease Modelling. London: Griffin.
16. MOOLGAVKAR, S. H., STEVENS, R. G. LEE, J. A. H. (1979). Effect of age on incidence of breast cancer in females. J. Nat. Cancer Inst. 62, 493-501.
17. MURDOCH, D. J., KREWSKI, D. CRUMP, K. S. (1987). Quantitative theories of carcinogenesis. In Cancer Modeling, Ed. J. R. Thompson and B. W. Brown, pp. 61-90. New York: Dekker.
18. PARMIGIANI, G. (1993a). On optimal screening ages. J. Am. Statist. Assoc. 88, 622-8.
19. PARMIGIANI, G. (1993b). Scheduling inspections in reliability. In Advances in Reliability, Ed. A. Basu, pp. 303-19. Amsterdam: North Holland.
20. PARMIGIANI, G. KAMLET, M. S. (1993). A cost-utility analysis of alternative strategies in screening for breast cancer. In Bayesian Statistics in Science and Technology. Case Studies, Ed. C. Gatsonis, J. Hodges, R. E. Kass and N. Singpurwalla, pp. 390-402. Berlin: Springer.
21. RUSTAGI, J. (1976). Variational Methods in Statistics. New York: Academic Press.
22. SHAHANI, A. K. CREASE, D. M. (1977). Towards models of screening for early detection of disease. Adv. Appl. Prob. 9, 665-80.
23. SHWARTZ, M. (1978). A mathematical model used to analyze breast cancer screening strategies. Oper. Res. 26, 937-55.
24. SKATES, S. J., Xu, F. J., Yu, Y. H., SJOVALL, K., EINHORN, N., CHANG, Y., BAST, R. C. KNAPP, R. C. (1995). Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer 76, 2004-10.
25. STRAATMAN, H., PEER, P. G. M. VERBEEK, A. L. M. (1997). Estimating lead time and sensitivity in a screening program without estimating the incidence in a screened group. Biometrics 53, 217-29.
26. TSODIKOV, A. D., ASSELAIN, B., FOURQUET, A., HoANG, T. YAKOVLEV, A. Y. (1995). Discrete strategies of cancer post treatment surveillance. Estimation and optimization problems. Biometrics 51, 437-47.
27. TSODIKOV, A. D. YAKOVLEV, A. Y. (1991). On the optimal policies of cancer screening. Math. Biosci. 107, 21-45.
28. VERDINELLI, I. KADANE, J. B. (1992). Bayesian designs for maximizing information and outcome. J. Am. Statist. Assoc. 87, 510-5.
29. WALTER, S. D. DAY, N. E. (1983). Estimation of the duration of a pre-clinical disease state using screening data. Am. J. Epidem. 118, 865-86.
30. WEISS, G. H. LINCOLN, T. L. (1966). Analysis of repeated examinations for the detection of occult disease. Health Serv. Res. 1, 272-86.
31. ZELEN, M. (1993). Optimal scheduling of examinations for the early detection of disease. Biometrika 80,279-94.
32. ZELEN, M. FEINLIB, M. (1969). On the theory of screening for chronic diseases. Biometrika 56, 601-14.